SCHEMBL4781073

SCHEMBL4781073

O=C(O)CCC(C(=O)O)N(O)O

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TET2 Q6N021 3/20 0.48
KDM4A O75164 2/20 0.48
KDM4C Q9H3R0 2/20 0.48
KDM2A Q9Y2K7 2/20 0.48
TET3 O43151 1/20 0.48
FOLH1 Q04609 10/20 0.46
CYP1A2 P05177 2/20 0.46
GRM3 Q14832 2/20 0.46
GRM8 O00222 1/20 0.46
GRM6 O15303 1/20 0.46
GRIN2D O15399 1/20 0.46
GRIN3B O60391 1/20 0.46
GSR P00390 1/20 0.46
GRIK1 P39086 1/20 0.46
GRM5 P41594 1/20 0.46
GRIA1 P42261 1/20 0.46
GRIA2 P42262 1/20 0.46
GRIA3 P42263 1/20 0.46
SLC1A3 P43003 1/20 0.46
SLC1A2 P43004 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4713126 1.00 TET2 (0.48) TET2KDM4AKDM4CKDM2ATET3
SCHEMBL2984816 0.81 CYP1A2 (0.48) TET2KDM4AKDM4CKDM2ATET3
SCHEMBL5324406 0.81 KMT2A (0.52) TET2KDM4AKDM4CKDM2ATET3
SCHEMBL2984814 0.81 CYP1A2 (0.48) TET2KDM4AKDM4CKDM2ATET3
SCHEMBL5324410 0.81 KMT2A (0.52) TET2KDM4AKDM4CKDM2ATET3
SCHEMBL27852564 0.79 TET2 (0.43) TET2KDM4AKDM4CKDM2ATET3
SCHEMBL8583489 0.78 CYP1A2 (0.50) TET2KDM4AKDM4CKDM2ATET3
SCHEMBL9183334 0.78 TET2 (0.46) TET2KDM4AKDM4CKDM2ATET3
SCHEMBL198528 0.78 CYP1A2 (0.50) TET2KDM4AKDM4CKDM2ATET3
SCHEMBL3379044 0.78 TET2 (0.52) TET2KDM4AKDM4CKDM2ATET3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110338050-A It is a kind of to plant training system and device with the Chinese herbal medicine of pre- preventing obesity and fat-reducing effect 湖南九层台环境科技有限公司 2019-10-18 CN disclosed
WO-2008005542-A2 ANTIVIRAL PHOSPHINATE COMPOUNDS GILEAD SCIENCES, INC., (US) 2008-01-10 WO disclosed
EP-1015417-A1 COMPOUNDS CONTAINING SIX-MEMBERED RINGS, PROCESSES FOR THEIR PREPARATION, AND THEIR USE AS MEDICAMENTS GILEAD SCIENCES, INC. (US) 2000-07-05 EP disclosed
WO-2000029385-A1 1,4,5,6-TETRAHYDRO-PYRIDAZINE DERIVATIVES, THEIR PREPARATION AND THEIR USE AS NEURAMINIDASE INHIBITORS GILEAD SCIENCES, INC. (US) 2000-05-25 WO disclosed
EP-0938475-A1 PIPERIDINE COMPOUNDS GILEAD SCIENCES, INC. (US) 1999-09-01 EP disclosed
WO-1999014185-A1 COMPOUNDS CONTAINING SIX-MEMBERED RINGS, PROCESSES FOR THEIR PREPARATION, AND THEIR USE AS MEDICAMENTS GILEAD SCIENCES, INC. (US) 1999-03-25 WO disclosed
WO-1999010365-A2 5',5'-LINKED OLIGOMERS HAVING ANTI-THROMBIN ACTIVITY GILEAD SCIENCES, INC. (US) 1999-03-04 WO disclosed
WO-1998017647-A1 PIPERIDINE COMPOUNDS GILEAD SCIENCES, INC. (US) 1998-04-30 WO disclosed
EP-0807118-A2 NOVEL COMPOUNDS AND METHODS FOR MAKING AND USING SAME GILEAD SCIENCES, INC. (US) 1997-11-19 EP disclosed
EP-0759917-A1 NOVEL SELECTIVE INHIBITORS OF VIRAL OR BACTERIAL NEURAMINIDASES GILEAD SCIENCES, INC. (US) 1997-03-05 EP disclosed
WO-1996026933-A9 NOVEL SELECTIVE INHIBITORS OF VIRAL OR BACTERIAL NEURAMINIDASES 1996-11-28 WO disclosed
WO-1996023801-A2 NOVEL COMPOUNDS AND METHODS FOR MAKING AND USING SAME GILEAD SCIENCES, INC. (US) 1996-08-08 WO disclosed
EP-0719273-A1 NUCLEOTIDE ANALOGS GILEAD SCIENCES, INC. (US) 1996-07-03 EP disclosed
WO-1995007920-A1 NUCLEOTIDE ANALOGS GILEAD SCIENCES, INC. (US) 1995-03-23 WO disclosed